Home » Topics » Disease categories and therapies » Urology

Urology
RSS

TES Pharma creates first potent and selective inhibitor of human ACMSD

March 2, 2018

Reata updates timeline for bardoxolone methyl studies in rare forms of chronic kidney disease

Feb. 28, 2018

Ionis licenses IONIS-AZ5-2.5Rx to AstraZeneca

Feb. 22, 2018

FDA issues complete response letter for Vitaros

Feb. 19, 2018

Pfizer patents novel C5a1 receptor antagonists

Feb. 16, 2018

Astellas divulges new melanocortin MC4 receptor agonists

Feb. 7, 2018

Cara Therapeutics begins pivotal phase III study of Korsuva in CKD-associated pruritus

Feb. 1, 2018

EMA committee hands down negative opinion for enclomiphene MAA

Jan. 29, 2018

Boehringer Ingelheim identifies novel cytochrome P450 11B2 inhibtors

Jan. 26, 2018

EMA committee gives positive opinion on orphan drug status for OMS-721

Jan. 23, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...